ReviewESMO open2022

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology.

C Gridelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.